Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”

Disease Markers - Egypt
doi 10.1155/2019/2790379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker

Cancers
Cancer ResearchOncology
2019English

ERRATUM: Acknowledgments Correction. Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer

Genomics and Informatics
EvolutionEcologyGeneticsSystematicsHealth InformaticsBehavior
2015English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

MDM2 Is a Useful Prognostic Biomarker for Resectable Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2013English

Identification of F5 as a Prognostic Biomarker in Patients With Gastric Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Comment On: Gene Expression Profiles for a Prognostic Immunoscore in Gastric Cancer

British Journal of Surgery
Surgery
2019English

Nuclear-Enriched Abundant Transcript 1 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Long Noncoding RNA LINC00978 Promotes Cancer Growth and Acts as a Diagnostic Biomarker in Gastric Cancer

Cell Proliferation
MedicineCell Biology
2017English

A Targeted Proteomics Approach Reveals a Serum Protein Signature as Diagnostic Biomarker for Resectable Gastric Cancer

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy